Capital Advisors »

Taysha Gene Therapies shares owned by Capital Advisors

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 79 0.00
2024-06-30 $0 79 0.00
2024-03-31 $0 79 0.00
2023-12-31 $0 79 0.00
2023-09-30 $0 79 0.00

More positions owned by Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Caesars Entertainment (CZR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Val Etf (IWD)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Msci Usa Min Vol (USMV)
Spdr Ser Tr S&p Divid Etf (SDY)
Ishares Tr S&p Mc 400gr Etf (IJK)
Ishares Tr Core Div Grwth (DGRO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Ishares Tr S&p 500 Grwt Etf (IVW)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Capital Advisors

Top funds holding Taysha Gene Therapies

BlackRock
BlackRock
RA Capital Management
VR Adviser
Morgan Stanley
Vanguard Group
Siren
Octagon Capital Advisors
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
Jpmorgan Chase & Co
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding Taysha Gene Therapies